New chemo strategy before surgery shows promise for pancreatic cancer
NCT ID NCT02959879
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study tested giving chemotherapy before surgery for people with pancreatic cancer that can be removed. The goal was to see if this approach helps patients live longer and have fewer complications. 153 participants received either standard treatment (surgery then chemo) or chemo before surgery with one of two drug combinations. The results help doctors understand if pre-surgery chemo improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE PANCREATIC DUCT ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rouen University Hospital
Rouen, France
Conditions
Explore the condition pages connected to this study.